CFTR and cystic fibrosis: Following the successful introduction of the β-adrenergic agonist, isoproterenol, to the KRB sequence, we next tested if our new rapid PD technique could detect whether CFTR gene delivery corrected the electrophysiological defect in CF mouse nasal airways towards a more normal phenotype, and whether the measurements were repeatable.